Mycophenolate mofetil in cadaveric renal transplantation

American Journal of Kidney Diseases

Volumn 34, Issue 2, 1999, Pages 296-303

  Cho, S ^a   Danovitch, G ^a   Deierhoi, M ^a   Ferguson, R ^a   Gonwa, T ^a   Hodge, E ^a   Johnson, C ^a   Miller, J ^a   Neylan, J L ^a   Norman, D ^a   Pescovitz, M D ^a   Sollinger, H W ^a   Tomlanovich, S J ^a   Weinstein, S ^a   Wang, W ^a   Rees, M M ^a   Ramos, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Graft survival; Mycophenolate mofetil; Patient survival; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ARTICLE; BLOOD TOXICITY; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0032774414     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70358-6     Document Type: Article

References (15)

1. HW Sollinger for the US Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225 232
2. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321 1325
3. A Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1996 1029 1037
4. AC Allison EM Eugui The design and development of an immunosuppressive drug, mycophenolate mofetil Springer Semin Immunopathol 14 1993 353 380
5. EM Eugui AC Allison Immunosuppressive activity of mycophenolate mofetil Ann NY Acad Sci 685 1993 308 329
6. TR Matthews Discovery and rationale for the development of mycophenolate mofetil R Lieberman A Mukherjee Principles of Drug Development in Transplantation and Autoimmunity 1996 Landes Austin, TX 335 337
7. AC Allison EM Eugui Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin Transplant 10 1996 77 84
8. P Halloran T Mathew S Tomlanovich C Groth L Hooftman C Barker for the International Mycophenolate Mofetil Renal Transplant Groups Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection Transplantation 63 1997 39 47
9. JM Cecka PI Terasaki The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing Clin Transplant 10 1994 1 18
10. JM Cecka PI Terasaki The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing Clin Transpl 11 1995 1 18
11. GP Basadonna AJ Matas KJ Gillingham WD Payne DL Dunn DE Sutherland PF Gores RW Gruessner JS Majarian Early versus late acute renal allograft rejection: Impact on chronic rejection Transplantation 55 1993 993 995
12. JM Cecka Early rejection: Determining the fate of renal transplants Transplant Proc 23 1991 1263 1264
13. DMJ Naimark E Cole Determinants of long-term renal allograft survival Transplant Rev 8 1994 93 113
14. TH Mathew A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group Transplantation 65 1998 1450 1454 [published erratum in Transplantation 66:817, 1998]
15. S Bergan HE Rugstad O Bentdal G Sodal A Hartmann T Leivestad O Stokke Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation Transplantation 66 1998 334 339